INSIGHTS ON CLINICAL TRIAL DESIGN

• Demonstrating IDS Value With Time-Based Metrics

  Explore how leading IDS pharmacies are using remote monitoring workflows and digital accountability systems to improve accuracy, reduce site burden, and maintain audit readiness.

• Delivering Cell & Gene Therapies Through Community Sites From Access To Execution

  This symposium from ASGCT 2026 explores community-based delivery of cell & gene therapies as a means to improve access, equity, enrollment speed, data quality, and regulatory evidence.

• The New Era Of Evidence Generation In Clinical Trials

  Learn how top pharmaceutical companies are using novel innovations to drive greater speed, scale, and access in clinical research than ever before in this webinar hosted by Musaddiq Khan, Vice President of DCT Solutions at Medable.

• Navigating Late-Phase Clinical Trial Enrollment: Strategies To Stay On Schedule

  Late-phase trial delays cause massive revenue loss. This piece outlines AI pre-screening, direct-to-patient scaling, and retention tactics to hit study goals on time and ensure market readiness.

• Addressing Trial Design Hurdles Across Alzheimer’s Disease Stages

  12/10/2025

  Explore how endpoint selection, rater training, and the strategic implementation of eCOA can help address the unique scientific, operational, and human considerations at each stage of AD.

• Best Practices In Rare Disease Patient Recruitment

  3/9/2026

  Recruiting for rare disease clinical trials is daunting, and making patients aware of clinical trials, involving them in trial design, and building trust are a few ways sponsors can boost recruitment.

• Why We Need To Look To The Future Of Clinical Trials

  1/6/2026

  Explore how decentralized trial elements, community-focused site networks, and patient-centric infrastructure can improve recruitment, data quality, equity, and efficiency.

• Advancing Dose Escalation Strategies With Bayesian Modeling

  8/12/2025

  A CRO was engaged to help a biotechnology sponsor develop a novel oncology therapy design and execute a multicenter, open-label Phase 1/2 dose escalation and expansion study in advanced solid tumors.

• Diversity In Clinical Trials: LGBTQIA+ Community Needs Not Just Allies, But Crusaders

  9/9/2024

  In an ACRP webinar on LGBTQIA+ diversity in clinical trials, industry panelists came together to discuss FDA action plans, SOGI data, advocacy efforts, challenges of transgender patients, and more.